Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-18

Clinical Trial Update: Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting results for Afrezza inhaled insulin used in combination with basal insulin (AID pump or insulin degludec) in adults with Type 1 d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Afrezza (Technosphere insulin)
  • insulin degludec (insulin degludec)

Snippet

Sponsor: Mannkind Corporation | Conditions: Type 1 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2024-10-18